Number of Negative Points:: A novel method for predicting radiosensitivity in head and neck tumor cell lines

被引:14
作者
Farnebo, Lovisa [1 ]
Jerhammar, Fredrik [1 ]
Vainikka, Linda [1 ]
Grenman, Reidar [2 ]
Norberg-Spaak, Lena [1 ]
Roberg, Karin [1 ]
机构
[1] Linkoping Univ Hosp, Div Otorhinolaryngol, SE-58185 Linkoping, Sweden
[2] Univ Turku, Cent Hosp & Univ Turku & Med Biochem, Dept Otorhinolaryngol Head & Neck Surg, SF-20500 Turku, Finland
关键词
predictive markers; p53; epidermal growth factor receptor; survivin; spuamous cell carcinoma;
D O I
10.3892/or_00000028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study was aimed at establishing a method that combines multiple factors of protein and genetic changes that enables prediction of radiosensitivity in the head and neck squamous cell carcinoma (HNSCC) cell lines. In nine HNSCC cell lines, the quantity of protein expression and the type of genetic alterations were translated into a point system, called the Number of Negative Points. The expression of 14 proteins involved in growth control and/or apoptosis was quantified using a densitometric assessment of Western blots. The blots were adjusted to actin and standardised to normal oral keratinocytes classifying them into four groups depending on the amount of protein expressed (0-3 points). Mutations of the p53 gene were classified into three groups and each mutation was given one point. Since the cell lines each had a known intrinsic radiosensitivity, a multivariate statistical calculation could then be performed to select for the combination of factors having the strongest correlation to radiosensitivity. The strongest correlation of the investigated factors was the combination of epidermal growth factor receptor, survivin and splice site/missense p53 mutations (R=0.990 and P < 0.0001). No single factor had a significant correlation to the intrinsic radiosensitivity. Since a significant correlation to the intrinsic radiosensitivity was achieved only when two or more factors were combined, we conclude that a method such as the Number of Negative Points is necessary for prediction of treatment response. We present a novel method to combine factors which enables the prediction of radiosensitivity of HNSCC cell lines.
引用
收藏
页码:453 / 461
页数:9
相关论文
共 50 条
[31]   Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines [J].
Oshima, Goro ;
Wennerberg, Johan ;
Yamatodani, Takashi ;
Kjellen, Elisabeth ;
Mineta, Hiroyuki ;
Johnsson, Anders ;
Ekblad, Lars .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (03) :491-499
[32]   Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines [J].
Goro Oshima ;
Johan Wennerberg ;
Takashi Yamatodani ;
Elisabeth Kjellén ;
Hiroyuki Mineta ;
Anders Johnsson ;
Lars Ekblad .
Journal of Cancer Research and Clinical Oncology, 2012, 138 :491-499
[33]   Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell Lines [J].
Wilkie, Mark D. ;
Anaam, Emad A. ;
Lau, Andrew S. ;
Rubbi, Carlos P. ;
Vlatkovic, Nikolina ;
Jones, Terence M. ;
Boyd, Mark T. .
CANCERS, 2021, 13 (19)
[34]   Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines [J].
Higuchi, Y ;
Asaumi, JI ;
Murakami, J ;
Matsuzaki, H ;
Wakasa, T ;
Inoue, T ;
Shigehara, H ;
Konouchi, H ;
Hisatomi, M ;
Kawasaki, S ;
Hiraki, Y ;
Kishi, K .
ONCOLOGY REPORTS, 2003, 10 (03) :671-677
[35]   Effects of serum starvation on radiosensitivity, proliferation and apoptosis in four human tumor cell lines with different p53 status [J].
Oya, N ;
Zölzer, F ;
Werner, F ;
Streffer, C .
STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (02) :99-106
[36]   Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines [J].
Ansell, Anna ;
Jerhammar, Fredrik ;
Ceder, Rebecca ;
Grafstrom, Roland ;
Grenman, Reidar ;
Roberg, Karin .
ORAL ONCOLOGY, 2009, 45 (10) :866-871
[37]   Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin [J].
Brands, Roman C. ;
Mueller-Richter, Urs D. A. ;
De Donno, Francesco ;
Seher, Axel ;
Mutzbauer, Grit ;
Linz, Christian ;
Kuebler, Alexander C. ;
Hartmann, Stefan .
MOLECULAR MEDICINE REPORTS, 2016, 13 (03) :2338-2344
[38]   Modifications of GST-μ and p53 gene expression in head and neck human tumor cell lines after gamma irradiation:: induction, cellular and molecular studies [J].
Dubessy, C ;
Merlin, JL ;
Marchal, C .
JOURNAL DE CHIMIE PHYSIQUE ET DE PHYSICO-CHIMIE BIOLOGIQUE, 1998, 95 (04) :718-723
[39]   DNMT1 Enhances the Radiosensitivity of HPV-Positive Head and Neck Squamous Cell Carcinomas via Downregulating SMG1 [J].
Zhang, Chunlin ;
Mi, Jiaoping ;
Deng, Yuan ;
Deng, Zeyi ;
Long, Dan ;
Liu, Zhaohui .
ONCOTARGETS AND THERAPY, 2020, 13 :4201-4211
[40]   Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents [J].
Harrington, K. J. ;
Kazi, R. ;
Bhide, S. A. ;
Newbold, K. ;
Nutting, C. M. .
INDIAN JOURNAL OF CANCER, 2010, 47 (03) :248-259